Literature DB >> 28319823

Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban.

Maeve P Crowley1, Maria J Cuadrado2, Beverley J Hunt3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28319823     DOI： 10.1016/j.thromres.2017.03.006

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

Review 1.  The rheumatology/hematology interface: CAPS and MAS diagnosis and management.

Authors:  John M Gansner; Nancy Berliner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment.

Authors:  Virginie Dufrost; Jessie Risse; Denis Wahl; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

4.  [Mechanisms and management of thrombosis and bleeding in antiphospholipid syndrome].

Authors:  Z Y Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

Review 5.  Clinical Management of Thrombotic Antiphospholipid Syndrome.

Authors:  Nor Rafeah Tumian; Beverley J Hunt
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.